Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
Analyst Downgrade
|
Expensive Performer
6131.5000
-0.50
(
-0.01
%)
NSE
Aug 29, 2025
15:31 PM
Volume:
283.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
10 Feb 2024
Analyst Downgrade
6131.50
-0.01%
Divi's Labs (SELL): Healthy margin recovery, heady valuations
Sell:
Divi's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 3000
Recommendation
Target
BOB Capital Markets Ltd.
Q3 revenue grew 9% YoY on 25% rise in custom synthesis business; API and nutraceuticals stayed soft
Divi's Laboratories Ltd. is trading
below its 30 day SMA
of 6332.4
More from Divi's Laboratories Ltd.
Recommended
Five Interesting Stocks Today - August 29, 2025
The Baseline |
29 Aug 2025
Market closes lower, Reliance Jio Infocomm to list by first half of 2026
Trendlyne Marketwatch |
29 Aug 2025
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022